CFO of Antigenics Inc. (AGEN, Financial) Shalini Sharp sells 1,950 shares of AGEN on 04/27/2010 at an average price of $1.16 a share.
Antigenics Inc. has a market cap of $105.8 million; its shares were traded at around $1.16 with and P/S ratio of 31.7.
Antigenics Inc. has a market cap of $105.8 million; its shares were traded at around $1.16 with and P/S ratio of 31.7.
CEO Recent Trades:
- Sell:: Chairman & CEO Garo H Armen sold 87,628 shares of AGEN stock on 03/11/2010 at the average price of 0.79, the price of the stock has increased by 46.84% since.
CFO Recent Trades:
- Sell:: CFO Shalini Sharp sold 63,848 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has increased by 36.47% since.
- Sell:: CFO Shalini Sharp sold 63,848 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has increased by 36.47% since.
Directors and Officers Recent Trades:
- Sell:: VP and General Counsel Karen Valentine sold 29,039 shares of AGEN stock on 03/16/2010 at the average price of 0.76, the price of the stock has increased by 52.63% since.
- Sell:: VP, Clin, Reg & Quality Kerry Wentworth sold 102,316 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has increased by 36.47% since.
- Sell:: VP and General Counsel Karen Valentine sold 93,789 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has increased by 36.47% since.
- Sell:: VP, Finance Christine M Klaskin sold 78,868 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has increased by 36.47% since.
- Sell:: VP, Clin, Reg & Quality Kerry Wentworth sold 102,316 shares of AGEN stock on 01/20/2010 at the average price of 0.85, the price of the stock has increased by 36.47% since.
